Finance

Lists
640:FRA
China Resources Pharmaceutical Group Ltd
€0.48
-0.83%
(-0.0040) 1D
Sep 9, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 640...
Open
€0.48
High
€0.48
Low
€0.48
Mkt. cap
26.98B
Avg. vol.
32.00
Volume
0.00
52-wk high
€0.71
52-wk low
€0.46
No. of employees
84K
Open
€0.48
High
€0.48
Low
€0.48
Mkt. cap
26.98B
Avg. vol.
32.00
Volume
0.00
52-wk high
€0.71
52-wk low
€0.46
No. of employees
84K
About China Resources Pharmaceutical Group Ltd
CEOBai Xiaosong
Employees84K
Founded2007
Headquarters-
SectorPharmaceutical industry
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
68.85B
68.85B
67.23B
67.23B
Cost of goods sold
57.35B
57.35B
56.46B
56.46B
Cost of revenue
57.35B
57.35B
56.46B
56.46B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.99B
7.99B
6.75B
6.75B
Operating expense
8.81B
8.81B
7.33B
7.33B
Total operating expenses
66.17B
66.17B
63.79B
63.79B
Operating income
2.69B
2.69B
3.44B
3.44B
Other non operating income
517.21M
517.21M
74.36M
74.36M
EBT including unusual items
2.69B
2.69B
3.22B
3.22B
EBT excluding unusual items
2.88B
2.88B
3.23B
3.23B
Income tax expense
390.24M
390.24M
710.64M
710.64M
Effective tax rate
14.51%
14.51%
22.05%
22.05%
Other operating expenses
818.33M
818.33M
582.42M
582.42M
Net income
984.09M
984.09M
1.09B
1.09B
Net profit margin
1.43%
1.43%
1.63%
1.63%
Earnings per share
-
-
-
-
Interest and investment income
106.35M
106.35M
100.23M
100.23M
Interest expense
-504.31M
-504.31M
-453.37M
-453.37M
Net interest expenses
-397.97M
-397.97M
-353.14M
-353.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
3.57B
3.57B
4.25B
4.25B
Gain or loss from assets sale
-19.57M
-19.57M
-
-
AI content may include mistakes. Learn more
Google apps